Total Funding
91
94
Total FundingPost-IPO Debt raised
Growth Score
2 pts
Heat Score
31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10805
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Michael S. Singer: Chief Scientific Officer, Director, Co-FounderPast Role: Topokine Therapeutics, Founder & CSO- Carsten Brunn: President, Chief Executive OfficerPast Role: Selecta Biosciences, President and CEO
About the Company
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
